Summary / Explanation
Introduction The Office of Disease Prevention and Health Promotion's (ODPHP) Healthy People 2030 vision is for "a society in which all people can achieve their full potential for health and well-being across the lifespan." To achieve this, 3 areas, "well-being, healthy life expectancy, and summary mortality and health," were identified to measure the health of the population (ODPHP. Healthy People 2030).
In a seminal paper, Kindig and Stoddart defined population health as "the health outcomes of a group of individuals, including the distribution of such outcomes within the group."[1] This definition embodies both outcomes or results and determinants or contributing factors. Compared to a more traditional approach of focusing on individual factors such as genetics and lifestyle, population health embraces additional determinants that may include healthcare policies, public health, and social and physical milieu.[1] Population health determinants can serve as a preventative approach and address root causes rather than symptoms like a biomedical approach.[2] Results from a recent scoping review found 57 frameworks, or organizational structures, to define the components of population health.[2] In addition to individual health status and health behavior, other crucial factors were identified, including social determinants of health and healthcare system performance.[2] The following sections will discuss several determinants of health. These factors do not make up a complete list of population health determinants, and their categorization varies in the literature, they also do not exist in isolation but rather in a complex, interrelated matrix (ODPHP. Healthy People 2030).[1]
Determinants of Health
Genetics and biology: The link between genetic factors and their physiologic outcomes in health and disease is part of population health. Links of family history to certain conditions (such as heart disease and depression) have been well-established.[3] This category can also include how extrinsic factors affect an individual's genome, such as smoking-induced deoxyribonucleic acid methylation at specific genomic loci.[3] The Framingham Heart Study, which began in Framingham, Massachusetts in 1948 (and is still ongoing), is considered the longest population-based cardiovascular study.[4][5] Landmark studies resulted from it, including those that identified key genetic factors, such as male sex and elevated cholesterol and blood pressure, as major risk factors for cardiovascular disease.[4][5] The study's data are part of a study that found hundreds of new loci for high blood pressure traits.[6]
Individual behavior and lifestyle: Individual behavior and lifestyle include intrinsic factors such as a patient's ability and motivation to engage in their health care and access to technology.[7] Extrinsic factors relating to individual behavior can include healthcare system factors like the ability to schedule appointments and the attitude and perceived skills of the healthcare providers.[7] Exposure to things such as tobacco, poor diet, alcohol, and firearms all fall under this domain.[7] The Framingham study established links between smoking, lack of physical activity, and cardiovascular disease.[4]
Social determinants: The World Health Organization defines the social determinants of health (SDOH) as "the conditions in which people are born, grow, work, live and age, and the wider set of forces and systems shaping the conditions of daily life" (ODPHP. Healthy People 2020 and 2030).[8] SDOH are nonclinical and nonbiological social factors that impact health. SDOH includes fundamental causes of disease such as racism and discrimination, unequal distribution of power, income, wealth, education, and societal values of equity and fairness that impact health directly and indirectly via intermediate structural factors, including healthcare access, healthcare quality, support services, housing and transportation and intermediate individual factors" (ODPHP. Healthy People 2020 and 2030).[8][9][10][11] Examples of SDOH domains include:
- Policy: The Institute of Medicine considers policy development a critical element of public health.[12] The government or healthcare organizations work to improve the health of a population. Examples include the Affordable Care Act, tobacco sales taxes, and car seatbelts (ODPHP. Healthy People 2020).[13] These are intended to be implemented in the population as a whole.
- Healthcare systems and services: This category relates to how healthcare is delivered and accessed by a population. Healthcare systems can be evaluated for their quality, patient-centeredness, and cost-effectiveness.[2]
- Physical environment factors: The physical environment of a population includes factors such as sanitation, quality housing, air pollution, and crowding. Personal control, socially supportive relationships, and restoration from stress and fatigue are all affected by the properties of the physical environment.[14]
- Ecological factors: Ecological factors also affect health based on the interconnectedness of living organisms and their environment.[15] Changes in the ecosystem brought about by climate change, loss of biodiversity, and ocean acidification, to name a few, can impact pollution, the availability and quality of clean air, water, food—and, subsequently, health.[16] Societal vulnerabilities in the form of infectious disease outbreaks and spread in nontraditional geographic regions have been documented as being due to increasing climate hazards such as severe flooding, extreme temperatures, and drought.[17]
The complex interrelatedness of these domains allows professionals working in population health to formulate a varied definition of population health.[2] This insight allows for inherent uniqueness when comparing various populations and targeting factors important for each one.[2] For clinicians, understanding the determinants of population health provides awareness of factors that can directly and indirectly affect the delivery of health care and influence individualized patient and population health outcomes. The more healthcare professionals educate themselves on determinants of population health, the more opportunities there will be to investigate, address, and overcome the barriers to providing optimized, versatile, and individualized patient care. Collectively, these efforts will lead to improved outcomes for patients and their communities.
Register For Free And Read The Full Article
- Search engine and full access to all medical articles
- 10 free questions in your specialty
- Free CME/CE Activities
- Free daily question in your email
- Save favorite articles to your dashboard
- Emails offering discounts
Learn more about a Subscription to StatPearls Point-of-Care
References
Kindig D, Stoddart G. What is population health? American journal of public health. 2003 Mar:93(3):380-3 [PubMed PMID: 12604476]
Chan SL, Ho CZH, Khaing NEE, Ho E, Pong C, Guan JS, Chua C, Li Z, Lim T, Lam SSW, Low LL, How CH. Frameworks for measuring population health: A scoping review. PloS one. 2024:19(2):e0278434. doi: 10.1371/journal.pone.0278434. Epub 2024 Feb 13 [PubMed PMID: 38349894]
Level 2 (mid-level) evidenceShi Y, Zhong S. From genomes to societies: a holistic view of determinants of human health. Current opinion in biotechnology. 2014 Aug:28():134-42. doi: 10.1016/j.copbio.2014.03.001. Epub 2014 Mar 28 [PubMed PMID: 24686286]
Level 3 (low-level) evidenceAndersson C, Nayor M, Tsao CW, Levy D, Vasan RS. Framingham Heart Study: JACC Focus Seminar, 1/8. Journal of the American College of Cardiology. 2021 Jun 1:77(21):2680-2692. doi: 10.1016/j.jacc.2021.01.059. Epub [PubMed PMID: 34045026]
Mahmood SS, Levy D, Vasan RS, Wang TJ. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet (London, England). 2014 Mar 15:383(9921):999-1008. doi: 10.1016/S0140-6736(13)61752-3. Epub 2013 Sep 29 [PubMed PMID: 24084292]
Level 3 (low-level) evidenceEvangelou E, Warren HR, Mosen-Ansorena D, Mifsud B, Pazoki R, Gao H, Ntritsos G, Dimou N, Cabrera CP, Karaman I, Ng FL, Evangelou M, Witkowska K, Tzanis E, Hellwege JN, Giri A, Velez Edwards DR, Sun YV, Cho K, Gaziano JM, Wilson PWF, Tsao PS, Kovesdy CP, Esko T, Mägi R, Milani L, Almgren P, Boutin T, Debette S, Ding J, Giulianini F, Holliday EG, Jackson AU, Li-Gao R, Lin WY, Luan J, Mangino M, Oldmeadow C, Prins BP, Qian Y, Sargurupremraj M, Shah N, Surendran P, Thériault S, Verweij N, Willems SM, Zhao JH, Amouyel P, Connell J, de Mutsert R, Doney ASF, Farrall M, Menni C, Morris AD, Noordam R, Paré G, Poulter NR, Shields DC, Stanton A, Thom S, Abecasis G, Amin N, Arking DE, Ayers KL, Barbieri CM, Batini C, Bis JC, Blake T, Bochud M, Boehnke M, Boerwinkle E, Boomsma DI, Bottinger EP, Braund PS, Brumat M, Campbell A, Campbell H, Chakravarti A, Chambers JC, Chauhan G, Ciullo M, Cocca M, Collins F, Cordell HJ, Davies G, de Borst MH, de Geus EJ, Deary IJ, Deelen J, Del Greco M F, Demirkale CY, Dörr M, Ehret GB, Elosua R, Enroth S, Erzurumluoglu AM, Ferreira T, Frånberg M, Franco OH, Gandin I, Gasparini P, Giedraitis V, Gieger C, Girotto G, Goel A, Gow AJ, Gudnason V, Guo X, Gyllensten U, Hamsten A, Harris TB, Harris SE, Hartman CA, Havulinna AS, Hicks AA, Hofer E, Hofman A, Hottenga JJ, Huffman JE, Hwang SJ, Ingelsson E, James A, Jansen R, Jarvelin MR, Joehanes R, Johansson Å, Johnson AD, Joshi PK, Jousilahti P, Jukema JW, Jula A, Kähönen M, Kathiresan S, Keavney BD, Khaw KT, Knekt P, Knight J, Kolcic I, Kooner JS, Koskinen S, Kristiansson K, Kutalik Z, Laan M, Larson M, Launer LJ, Lehne B, Lehtimäki T, Liewald DCM, Lin L, Lind L, Lindgren CM, Liu Y, Loos RJF, Lopez LM, Lu Y, Lyytikäinen LP, Mahajan A, Mamasoula C, Marrugat J, Marten J, Milaneschi Y, Morgan A, Morris AP, Morrison AC, Munson PJ, Nalls MA, Nandakumar P, Nelson CP, Niiranen T, Nolte IM, Nutile T, Oldehinkel AJ, Oostra BA, O'Reilly PF, Org E, Padmanabhan S, Palmas W, Palotie A, Pattie A, Penninx BWJH, Perola M, Peters A, Polasek O, Pramstaller PP, Nguyen QT, Raitakari OT, Ren M, Rettig R, Rice K, Ridker PM, Ried JS, Riese H, Ripatti S, Robino A, Rose LM, Rotter JI, Rudan I, Ruggiero D, Saba Y, Sala CF, Salomaa V, Samani NJ, Sarin AP, Schmidt R, Schmidt H, Shrine N, Siscovick D, Smith AV, Snieder H, Sõber S, Sorice R, Starr JM, Stott DJ, Strachan DP, Strawbridge RJ, Sundström J, Swertz MA, Taylor KD, Teumer A, Tobin MD, Tomaszewski M, Toniolo D, Traglia M, Trompet S, Tuomilehto J, Tzourio C, Uitterlinden AG, Vaez A, van der Most PJ, van Duijn CM, Vergnaud AC, Verwoert GC, Vitart V, Völker U, Vollenweider P, Vuckovic D, Watkins H, Wild SH, Willemsen G, Wilson JF, Wright AF, Yao J, Zemunik T, Zhang W, Attia JR, Butterworth AS, Chasman DI, Conen D, Cucca F, Danesh J, Hayward C, Howson JMM, Laakso M, Lakatta EG, Langenberg C, Melander O, Mook-Kanamori DO, Palmer CNA, Risch L, Scott RA, Scott RJ, Sever P, Spector TD, van der Harst P, Wareham NJ, Zeggini E, Levy D, Munroe PB, Newton-Cheh C, Brown MJ, Metspalu A, Hung AM, O'Donnell CJ, Edwards TL, Psaty BM, Tzoulaki I, Barnes MR, Wain LV, Elliott P, Caulfield MJ, Million Veteran Program. Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits. Nature genetics. 2018 Oct:50(10):1412-1425. doi: 10.1038/s41588-018-0205-x. Epub 2018 Sep 17 [PubMed PMID: 30224653]
Level 2 (mid-level) evidencevan Kessel R, Ranganathan S, Anderson M, McMillan B, Mossialos E. Exploring potential drivers of patient engagement with their health data through digital platforms: A scoping review. International journal of medical informatics. 2024 Sep:189():105513. doi: 10.1016/j.ijmedinf.2024.105513. Epub 2024 Jun 5 [PubMed PMID: 38851132]
Level 2 (mid-level) evidenceSkolarus LE, Sharrief A, Gardener H, Jenkins C, Boden-Albala B. Considerations in Addressing Social Determinants of Health to Reduce Racial/Ethnic Disparities in Stroke Outcomes in the United States. Stroke. 2020 Nov:51(11):3433-3439. doi: 10.1161/STROKEAHA.120.030426. Epub 2020 Oct 26 [PubMed PMID: 33104471]
Gómez CA, Kleinman DV, Pronk N, Wrenn Gordon GL, Ochiai E, Blakey C, Johnson A, Brewer KH. Addressing Health Equity and Social Determinants of Health Through Healthy People 2030. Journal of public health management and practice : JPHMP. 2021 Nov-Dec 01:27(Suppl 6):S249-S257. doi: 10.1097/PHH.0000000000001297. Epub [PubMed PMID: 33729197]
Marmot M. Social determinants of health inequalities. Lancet (London, England). 2005 Mar 19-25:365(9464):1099-104 [PubMed PMID: 15781105]
Schulz AJ, Kannan S, Dvonch JT, Israel BA, Allen A 3rd, James SA, House JS, Lepkowski J. Social and physical environments and disparities in risk for cardiovascular disease: the healthy environments partnership conceptual model. Environmental health perspectives. 2005 Dec:113(12):1817-25 [PubMed PMID: 16330371]
Level 3 (low-level) evidenceInstitute of Medicine (US) Committee on Assuring the Health of the Public in the 21st Century. The Future of the Public's Health in the 21st Century. 2002:(): [PubMed PMID: 25057638]
Zhao J, Mao Z, Fedewa SA, Nogueira L, Yabroff KR, Jemal A, Han X. The Affordable Care Act and access to care across the cancer control continuum: A review at 10 years. CA: a cancer journal for clinicians. 2020 May:70(3):165-181. doi: 10.3322/caac.21604. Epub 2020 Mar 23 [PubMed PMID: 32202312]
Evans GW. The built environment and mental health. Journal of urban health : bulletin of the New York Academy of Medicine. 2003 Dec:80(4):536-55 [PubMed PMID: 14709704]
Parkes MW, Poland B, Allison S, Cole DC, Culbert I, Gislason MK, Hancock T, Howard C, Papadopoulos A, Waheed F. Preparing for the future of public health: ecological determinants of health and the call for an eco-social approach to public health education. Canadian journal of public health = Revue canadienne de sante publique. 2020 Feb:111(1):60-64. doi: 10.17269/s41997-019-00263-8. Epub 2019 Dec 2 [PubMed PMID: 31792844]
Level 2 (mid-level) evidenceLi AM. Ecological determinants of health: food and environment on human health. Environmental science and pollution research international. 2017 Apr:24(10):9002-9015. doi: 10.1007/s11356-015-5707-9. Epub 2015 Nov 10 [PubMed PMID: 26552789]
Level 2 (mid-level) evidenceSemenza JC, Rocklöv J, Ebi KL. Climate Change and Cascading Risks from Infectious Disease. Infectious diseases and therapy. 2022 Aug:11(4):1371-1390. doi: 10.1007/s40121-022-00647-3. Epub 2022 May 19 [PubMed PMID: 35585385]